Abstract:Myelin is the lipidic insulating structure enwrapping axons and allowing fast saltatory nerve conduction. In the central nervous system, myelin sheath is the result of the complex packaging of multilamellar extensions of oligodendrocyte (OL) membranes. Before reaching myelinating capabilities, OLs undergo a very precise program of differentiation and maturation that starts from OL precursor cells (OPCs). In the last 20 years, the biology of OPCs and their behavior under pathological conditions have been studied through several experimental models. When co-cultured with neurons, OPCs undergo terminal maturation and produce myelin tracts around axons, allowing to investigate myelination in response to exogenous stimuli in a very simple in vitro system. On the other hand, in vivo models more closely reproducing some of the features of human pathophysiology enabled to assess the consequences of demyelination and the molecular mechanisms of remyelination, and they are often used to validate the effect of pharmacological agents. However, they are very complex, and not suitable for large scale drug discovery screening. Recent advances in cell reprogramming, biophysics and bioengineering have allowed impressive improvements in the methodological approaches to study brain physiology and myelination. Rat and mouse OPCs can be replaced by human OPCs obtained by induced pluripotent stem cells (iPSCs) derived from healthy or diseased individuals, thus offering unprecedented possibilities for personalized disease modeling and treatment. OPCs and neural cells can be also artificially assembled, using 3D-printed culture chambers and biomaterial scaffolds, which allow modeling cell-to-cell interactions in a highly controlled manner. Interestingly, scaffold stiffness can be adopted to reproduce the mechanosensory properties assumed by tissues in physiological or pathological conditions. Moreover, the recent development of iPSC-derived 3D brain cultures, called organoids, has made it possible to study key aspects of embryonic brain development, such as neuronal differentiation, maturation and network formation in temporal dynamics that are inaccessible to traditional in vitro cultures. Despite the huge potential of organoids, their application to myelination studies is still in its infancy. In this review, we shall summarize the novel most relevant experimental approaches and their implications for the identification of remyelinating agents for human diseases such as multiple sclerosis.

Testosterone and Myelin Regeneration in the Central Nervous System

Interplay between androgen and CXCR4 chemokine signaling in myelin repair

Testosterone Reduces Myelin Abnormalities in the Wobbler Mouse Model of Amyotrophic Lateral Sclerosis

Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex

Clinical implications of myelin regeneration in the central nervous system

The Effects of Neuroactive Steroids On Myelin in Health and Disease

Regulatory T cells promote myelin regeneration in the central nervous system

17 Beta-Estradiol Enhances Schwann Cell Differentiation Via The Er Beta-Erk1/2 Signaling Pathway And Promotes Remyelination In Injured Sciatic Nerves

[Neuroscience] Remyelination in the Central Nervous System

17β-Estradiol Enhances Schwann Cell Differentiation via the ERβ-ERK1/2 Signaling Pathway and Promotes Remyelination in Injured Sciatic Nerves

Remyelination in the CNS: from biology to therapy

Dihydrotestosterone reduces neuroinflammation in spinal cord injury through NF-κB and MAPK pathway

Demyelination as a rational therapeutic target for ischemic or traumatic brain injury.

Promoting peripheral myelin repair

Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation

Novel in vitro Experimental Approaches to Study Myelination and Remyelination in the Central Nervous System

Nuclear hormone receptors in demyelinating diseases

Repair of Myelin Disease: Strategies and Progress in Animal Models

Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease

Regenerative Capacity of Macrophages for Remyelination

Rejuvenation of Regeneration in the Aging Central Nervous System.